News | November 19, 2014

Guerbet to Exhibit Recently Approved Imaging Agents at RSNA

Dotarem (gadoterate meglumine) injection and Lipiodol (ethiodized oil) injection to be presented at Guerbet booths

Dotarem Injection, Lipiodol Injection, RSNA 2014, MRI

Image Courtesy of Guerbet

November 19, 2104 —Guerbet will present its two latest contrast agents, Dotarem (gadoterate meglumine) injection and Lipiodol (ethiodized oil) injection, at the 100th annual Radiological Society of North America (RSNA) Nov. 30 through Dec. 6 in Chicago.

In addition to its exhibit, five abstracts from studies, for which Guerbet provided financial support, have been accepted by RSNA for this year's meeting.

Dotarem (gadoterate meglumine) injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain, spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier and/or abnormal vascularity. It received U.S. Food and Drug Administration approval in March 2013. As of Aug. 31, 2014 there have been more than 48 million Dotarem doses administered worldwide.

For more information: www.guerbet.com

Related Content

HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | CT Angiography (CTA) | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
New MRI Sensor Can Image Activity Deep Within the Brain
News | Magnetic Resonance Imaging (MRI) | March 15, 2019
Calcium is a critical signaling molecule for most cells, and it is especially important in neurons. Imaging calcium in...
Podcast | Cardiac Imaging | March 15, 2019
Debate About Coronary Testing Highlights ACC Session
Canon Medical Introduces Entry-Level Aquilion Start CT
News | Computed Tomography (CT) | March 14, 2019
Canon Medical Systems Europe B.V. introduced the all-new Aquilion Start computed tomography (CT) system to the European...
Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT
News | Computed Tomography (CT) | March 14, 2019
Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Iron Measurements With MRI Reveal Stroke's Impact on Brain

Images show illustrative examples of visual R2? modifications within substantia nigra (SN) at baseline (24-72 h) and follow-up (1 y) in striatum (participants 1 and 2) and control groups (participants 3 and 4). Image courtesy of the Radiological Society of North America (RSNA).

News | Stroke | March 12, 2019
March 12, 2019 — A simple ...
Siemens Healthineers Announces First U.S. Install of Magnetom Sola 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | March 04, 2019
South Texas Radiology Imaging Centers, San Antonio, recently became the first healthcare institution in the United...
Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool
News | Computed Tomography (CT) | March 04, 2019
Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked...